What Researchers Did
This study reviewed over 100 publications, including eight randomized controlled trials, to evaluate hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss.
What They Found
Researchers found that hyperbaric oxygen therapy, when initiated within two weeks of symptom onset and combined with corticosteroids, yielded the best results. Patients experienced an average hearing gain of 19.3 dB for moderate hearing loss and 37.7 dB for severe cases, moving deficits from moderate/severe to slight/no impairment.
What This Means for Canadian Patients
Canadian patients experiencing idiopathic sudden sensorineural hearing loss could potentially benefit from hyperbaric oxygen therapy combined with corticosteroids. This treatment, if started early, may significantly improve hearing and enhance their quality of life.
Canadian Relevance
This study does not have a direct Canadian connection.
Study Limitations
As a literature review, this study's findings are dependent on the quality and methodologies of the previously published research it synthesized.